In a regulatory filing, Vera Therapeutics (VERA) disclosed that its Patrick Enright bought 5.9K shares of common stock on December 11th in a total transaction size of $250K.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VERA:
- Vera Therapeutics price target raised to $33 from $23 at Wedbush
- Vera Therapeutics Completes Successful Stock Offering
- Vera Therapeutics 6.14M share Secondary priced at $42.50
- Vera Therapeutics offers to sell up to $200M in common stock
- Vera Therapeutics price target raised to $97 from $75 at Evercore ISI